CAS RN: 132682-22-5
4-Oxazolidinecarboxylicacid,2-oxo-,methylester,(4S)-(9CI)
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260331
1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 132682-22-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Shanghai
Inquiry
132682-22-5 / methyl (4S)-2-oxo-1,3-oxazolidine-4-carboxylate
Standard CAS: 132682-22-5
Multi CAS: No
Basic Information
copy
CAS
132682-22-5 copy
Multi CAS
No copy
Molecular Formula
C5H7NO4 copy
Molecular Weight
145.110000 copy
Exact Mass
145.037508 copy
SMILES
COC(=O)[C@@H]1COC(=O)N1 copy
InChI
InChI=1S/C5H7NO4/c1-9-4(7)3-2-10-5(8)6-3/h3H,2H2,1H3,(H,6,8)/t3-/m0/s1 copy
InChIKey
PZIWTVKXOORXAZ-VKHMYHEASA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
0.6 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
30.29 copy
TPSA
64.63 copy
LogP / Solubility
WLOGP
-0.73 copy
MLOGP
-0.65 copy
XLogP3
-0.3 copy
Consensus LogP
-0.56 copy
Log S (ESOL)
-0.21 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.22 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.12 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
Low copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.13 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy